SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-166631
Filing Date
2017-05-11
Accepted
2017-05-11 08:01:57
Documents
57
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d382380d10q.htm 10-Q 298232
2 EX-31.1 d382380dex311.htm EX-31.1 8823
3 EX-31.2 d382380dex312.htm EX-31.2 8663
4 EX-32.1 d382380dex321.htm EX-32.1 4480
  Complete submission text file 0001193125-17-166631.txt   2825757

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crsp-20170331.xml EX-101.INS 433363
6 XBRL TAXONOMY EXTENSION SCHEMA crsp-20170331.xsd EX-101.SCH 40116
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20170331_cal.xml EX-101.CAL 53691
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20170331_def.xml EX-101.DEF 150619
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20170331_lab.xml EX-101.LAB 345912
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20170331_pre.xml EX-101.PRE 245124
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 17832569
SIC: 2836 Biological Products, (No Diagnostic Substances)